HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells

[1]  Yue Meng,et al.  Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation , 2016, Apoptosis.

[2]  B. Prabhakar,et al.  Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis , 2016, Cell Death Discovery.

[3]  Hui-Yun Wang,et al.  Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma , 2016, Aging.

[4]  L. Cappabianca,et al.  NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis , 2016, Cell Death Discovery.

[5]  Y. S. Shin,et al.  Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[6]  D. P. Mishra,et al.  Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells , 2015, Front. Oncol..

[7]  Weili Zhao,et al.  c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors , 2014, Journal of Hematology & Oncology.

[8]  H. Walczak,et al.  Getting TRAIL back on track for cancer therapy , 2014, Cell Death and Differentiation.

[9]  E. Seto,et al.  Erasers of histone acetylation: the histone deacetylase enzymes. , 2014, Cold Spring Harbor perspectives in biology.

[10]  K. Ramana,et al.  Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors. , 2013, Free radical biology & medicine.

[11]  Y. S. Shin,et al.  AY4, an agonistic anti-death receptor 4 MAB, induces apoptotic cell death in anaplastic thyroid cancer cells via downregulation of Bcl-xL with reactive oxygen species generation. , 2013, Endocrine-related cancer.

[12]  Y. S. Shin,et al.  An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation. , 2012, Cancer letters.

[13]  Louise Fairall,et al.  A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death , 2012, Molecular cell.

[14]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[15]  D. Dimitrov,et al.  Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibody , 2010, mAbs.

[16]  Junho Chung,et al.  Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells , 2010, Apoptosis.

[17]  T. Bayer,et al.  Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein* , 2010, The Journal of Biological Chemistry.

[18]  D. Saur,et al.  HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells , 2010, Molecular Cancer.

[19]  Yong-Sung Kim,et al.  A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes , 2009, Molecular Cancer Therapeutics.

[20]  W. Westra,et al.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. , 2009, Annual review of pathology.

[21]  Minoru Yoshida,et al.  14-3-3 regulates the nuclear import of class IIa histone deacetylases. , 2008, Biochemical and biophysical research communications.

[22]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[23]  Michele Pallaoro,et al.  HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics , 2007, Cell Research.

[24]  E. Sausville,et al.  Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma. , 2005, Neoplasia.

[25]  K. Harish.  Neck dissections: radical to conservative , 2005, World journal of surgical oncology.

[26]  Wafik S El-Deiry,et al.  TRAIL and apoptosis induction by TNF-family death receptors , 2003, Oncogene.

[27]  S. Shankar,et al.  Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. , 2003, Cancer research.

[28]  A. Rustgi,et al.  Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery* , 2001, The Journal of Biological Chemistry.

[29]  A. Rustgi,et al.  Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery. , 2001, The Journal of biological chemistry.

[30]  Barry I. Posner,et al.  Regulation of Histone Deacetylase 4 by Binding of 14-3-3 Proteins , 2000, Molecular and Cellular Biology.

[31]  P. Marks,et al.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.

[32]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[33]  E. Martz.  Radical or conservative? , 1999, Delaware medical journal.

[34]  J. Tschopp,et al.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.